MyFinsight
Home
Blog
About
Contact
Download
Download image
Stock-based compensation
expense
$45,893K
Depreciation and
amortization
$40,771K
Accounts receivable
-$6,876K
Accrued compensation
$5,732K
Accounts payable
$3,078K
Operating lease assets
-$1,372K
Other accrued and
current liabilities
$870K
Other
-$153K
Net cash provided by
(used in) operating...
$64,347K
Canceled cashflow
$40,398K
Net revenues from
external customers
$344,229K
Net change in cash
and cash...
-$2,980K
Canceled cashflow
$64,347K
Proceeds from maturities
of marketable...
$189,200K
Proceeds from sale of
equity securities
$1,533K
Proceeds from sale of
property and equipment
$45K
Proceeds from
contributions to the employee...
$2,416K
Proceeds from exercise of
common stock options
$2,206K
Proceeds from lease
incentives received
$190K
Net (loss) income
-$24,158K
Deferred income taxes
-$6,228K
Accretion of discounts on
marketable investment...
$4,219K
Inventory
$2,142K
Net gains on equity
securities
$1,466K
Operating lease
liabilities
-$1,275K
Prepaid expenses and
other current assets
$544K
Other assets
$366K
Canceled cashflow
$344,229K
Net cash used in
investing activities
-$60,367K
Canceled cashflow
$190,778K
Net cash (used in)
provided by financing...
-$6,960K
Canceled cashflow
$4,812K
Personnel costs
$209,816K
Other segment items
$65,500K
Organizational and marketing
costs
$51,545K
Inventory usage
$21,821K
Professional services
$10,928K
Clinical studies and
publication costs
$8,777K
Purchases of marketable
investment securities
$188,714K
Purchases of property and
equipment
$36,021K
Asset acquisition,
net of cash and cash...
$18,727K
Purchases of debt
securities classified as...
$5,569K
Issuance of loan
receivable
$2,114K
Payment of employees
taxes on vested...
$11,657K
Repayment of principal
portion of finance lease...
$115K
Back
Back
Cash Flow
source: myfinsight.com
CASTLE BIOSCIENCES INC (CSTL)
CASTLE BIOSCIENCES INC (CSTL)